Access cutting-edge mantle cell lymphoma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access mantle cell lymphoma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mantle cell lymphoma treatment provided free
The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus zanubrutinib versus zanubrutinib plus placebo.
Sponsor: BeiGene
Check if you qualify for this mantle cell lymphoma clinical trial in Chicago, IL
If you're searching for mantle cell lymphoma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mantle cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.